(Q33598665)

28 July 2017

title

Use of a tiered review for evaluation of appropriate use of hydroxymethylglutaryl coenzyme A reductase-inhibitor therapy (English)

1 reference

28 July 2017

Strauss WE

1

1 reference

28 July 2017

Alexis G

series ordinal

2

1 reference

28 July 2017

Tapley RD

series ordinal

3

1 reference

28 July 2017

publication date

1 February 1999

1 reference

28 July 2017

published in

Clinical Therapeutics

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

422-429

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Cost and health implications of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Divergent reporting of coronary risk factors before coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988297-1

7 January 2021

10.1016/S0149-2918(00)88297-1

Identifiers

DOI

1 reference

28 July 2017

1 reference